Effectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load

Purpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results...

Descripción completa

Detalles Bibliográficos
Autores: Imaz, Arkaitz, Llibre, Josep María, Navarro Bernabé, Joan, Curto, J. J. (Jorge Juan), Clotet, Bonaventura, 1953-, Crespo, M., Murillo Rubio, Óscar, Ferrer, Elena, Saumoy, Maria, Tiraboschi, Juan Manuel, Podzamczer Palter, Daniel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/126488
Acceso en línea:https://hdl.handle.net/2445/126488
Access Level:acceso abierto
Palabra clave:Infeccions per VIH
Antiretrovirals
HIV infections
Antiretroviral agents
Descripción
Sumario:Purpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results have been reported. We compared the effectiveness between NNRTI and PI/r as first-line cART fof HIV-1-infected patients with high pVL.

Similares en LA Referencia